The contamination of aquatic ecosystems by pharmaceutical residues, particularly ciprofloxacin (CIX), can pose severe environmental and public health risks. This study aimed to optimize the photodegradation of CIX from pharmaceutical industrial wastewater using N-doped TiO2/Biochar Nanocomposites. A novel N-doped TiO2/BC nanocomposite was synthesized via sol–gel techniques and evaluated under UV and sunlight irradiation. Kinetic degradation parameters were optimized using Response Surface Methodology (RSM) with a Central Composite Design (CCD). The optimized conditions included a contact time of 72 min, a pH of 6.9, a nanocomposite dosage of 2 g/L, and an initial CIX concentration of 50 mg/L. Maximum degradation efficiencies of 98.9% and 96.9% were achieved under UV and visible light, respectively. The statistical evaluation confirmed the model's validity and adequacy, with a high F-value (86,345) and significant model terms (p < 0.0001). Additionally, the lack-of-fit test yielded a non-significant value (p = 0.93), indicating an excellent fit of the model to the data. The determination coefficients (R2 0.98, adjusted R2 = 0.93, and predicted R2 = 0.96) further supported the model's robustness and predictive accuracy. The optimized parameters were applied to real pharmaceutical wastewater, achieving degradation efficiencies of 86.9% and 84.3% for UV and sunlight, respectively. These findings highlight the potential of N-doped TiO2/BC nanocomposites for efficient CIX degradation and pharmaceutical pollutant removal by modifying the limitations of pristine TiO2. Further, it solves scaling up the process and optimizes photocatalyst selection, stability, and reusability for practical environmental applications.
Ashebir et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: